Hematologic Cancer Area

"Our increased knowledge and advances in treatment with immunotherapy and advanced therapies have transformed the medical care of patients who suffer from haematological cancer in recent years".


The Hematological Cancer Department of the Cancer Center Clínica Universidad de Navarra is made up of specialists of national and international prestige.

The multidisciplinary nature of the team allows the integration of classical anatomopathological, cytological and imaging diagnostic techniques with the latest generation of immunological and molecular studies, which enables a more precise and rapid diagnosis and the use of new personalized treatments for malignant diseases of the blood and lymphatic system.

The joint work of medical and research staff facilitates the development and application of new treatments and the accurate evaluation of their results.

We are experts in the development of advanced cellular therapies, including hematopoietic progenitor transplantation, adoptive cellular immunotherapies such as CAR-T cells, dendritic cell therapies, or the use of activated lymphocytes for the treatment of infections. These treatments are developed in conjunction with the Cell Therapy Area.

In the field of lymphomas, myeloid neoplasms and, especially, in myelomas and monoclonal gammopathies, we are an international reference center, with leadership in some of the clinical trials that have allowed the development of new drugs directed to specific targets, immunoconjugated antibodies, bispecific and CART therapy.


Second Opinion,
peace of mind

Request a second opinion from our professionals with great experience in the diagnosis and treatment of oncological diseases

In 3 days, without leaving home.

Comprehensive care for our patients



Do you need to request a consultation with one of our specialists?

Learn more about our clinical trials

New therapeutic possibilities and advances for our patients

Imagen de un icono gris oscuro de un microscopio.

Myeloma and monoclonal gammopathies

Imagen de un icono gris oscuro de un microscopio.

Lymphomas and solid tumours

Imagen de un icono gris oscuro de un microscopio.

Myelodysplastic, myeloproliferative syndromes and acute leukemias

A multidisciplinary team of renowned prestige being at the forefront


Advanced Therapy Unit

The Advanced Therapies Unit of Clínica Universidad de Navarra has been established in order to deal exclusively with cellular therapies against cancer and other diseases of the immune system, favouring their administration and seeking to increase the safety of these treatments.

A multidisciplinary team of highly specialised nurses together with physicians from all the specialities involved in the approach to those treatments that depend on advanced therapy drugs and immunotherapy


Therapeutic advances

Our primary objective is to enable the patient who comes to our office to receive comprehensive information, based on knowledge of the natural history of the disease, an accurate immunological and molecular diagnosis, with up-to-date therapeutic guidance, including the possibility of receiving state-of-the-art treatments and promising new drugs in the context of clinical trials, and human support from our medical and nursing staff.

GMP Cell Therapy Laboratory

This laboratory produces advanced therapy medicines under good manufacturing practices and is authorised by the Spanish Agency for Medicines and Health Products.

Specialized Nursing

Its role is focused on the monitoring of the therapeutic process, the palliation of possible adverse symptoms caused by the medication and the prevention of possible complications.

Excellence in research

The Clínica Universidad de Navarra is a pioneer in the field of cancer research and the treatment of other diseases related to the immune system.

Imagen de la fachada de consultas de la sede en Pamplona de la Clínica Universidad de Navarra

Why choose the Clinic?

  • International reference multidisciplinary team.
  • Highly specialised nursing team.
  • First GMP Cell Therapy Laboratory accredited in a hospital within the National Health System.

Our team of professionals


Research and assistance

The collaborative group of professionals from the CIMA Universidad de Navarra and Clinic aims to understand the mechanism of transformation of normal blood cells into tumour cells in order to develop more effective treatments. Investigates minimal residual disease that may persist after treatments, its implication in relapses and strategies for its eradication.

In the laboratories of the Cima, the origin of haematological diseases is studied in order to make the transition to clinical care through clinical trials and the development of new drugs.

We help our patients overcome their stories

Your testimonials encourage us to continue improving our services.